Status:
COMPLETED
Design of Patient Specific Guides (PSG) for Reverse Shoulder Arthroplasty
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions:
Proximal Humeral Fracture
Eligibility:
All Genders
50-90 years
Brief Summary
This is a two steps observational study In the first part we will compare the accuracy of the commercial guide against a in-hospital designed patient specific guide. As a secondary goal, the problems...
Detailed Description
Reverse shoulder arthroplasty is a treatment for both non-synthesizable fractures and arthropathy degenerative. This implant is based on two main components: glenosphere and stem. The stem in turn is ...
Eligibility Criteria
Inclusion
- Patient with proximal humerus fracture candidate for reversed shoulder arthroplasty
- Patient with degenerative arthropathy candidate for reversed shoulder arthroplasty
Exclusion
- Previous surgeries on the proximal humerus or glenoid
- No desire to participate in the study
- Lack of ability to accept the study (tutored patients)
- Open fractures
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 23 2024
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT06611059
Start Date
April 1 2023
End Date
January 23 2024
Last Update
November 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona, Spain, 08025